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Abstract.  Two clonal rat rhabdomyosarcoma cell lines 
BA-Han-IB and BA-Han-IC with different capacities 
for myogenic differentiation have been examined for 
the expression of muscle regulatory basic helix-loop- 
helix (bHLH) proteins of the MyoD family. Whereas 
cells of the BA-Han-IC subpopulation constitutively 
expressed MyoD1 and could be induced to differenti- 
ate with retinoic acid (RA), BA-Han-IB cells did not 
express any of the myogenic control factors and ap- 
peared to be largely differentiation-defective.  Upon in- 
duction with RA, BA-Han-IC cells expressed also 
myogenin, in contrast to BA-Han-IB cells which never 
activated any of the genes encoding muscle bHLH fac- 
tors.  The onset of myogenin transcription  in BA-Han- 
1C cells required de novo protein synthesis and DNA 
replication suggesting that RA probably did not act 
directly on the myogenin gene. Although MyoD1 was 
expressed in proliferating BA-Han-IC myoblasts, 
muscle-specific reporter genes were not activated indi- 
cating that MyoD was biologically inactive.  However, 
transfections with plasmid expressing additional 
MyoD1 protein resulted in the transactivation  of mus- 
cle genes even in the absence of RA. mRNA encoding 
the negative regulatory HLH protein Id was expressed 
in proliferating BA-Han-IC cells and disappeared later 
after RA induction which suggested that it may be in- 
volved in the regulation of MyoD1 activity. The myo- 
genic differentiation of malignant rhabdomyosarcoma 
cells strictly correlated with the activation of the myo- 
genin gene. In fact,  stable transfections of BA-Han-IC 
cells with myogenin expressing plasmids resulted in 
spontaneous differentiation.  Taken together,  our results 
suggest that the transformed and undifferentiated 
phenotype of BA-Han-IC rhabdomyosarcoma cells is 
associated with the inactivation of the myogenic factor 
MyoD1 as well as lack of myogenin expression.  RA 
alleviates the inhibition of myogenic differentiation, 
probably by activating MyoD protein and myogenin 
gene transcription.  BA-Han-IB cells did not respond to 
RA and the differentiated phenotype could not be re- 
stored by overexpression of MyoD1 or myogenin. 
T 
RANSFORMATION  of normal cells to a malignant phe- 
notype is believed to involve multistep  mechanisms 
which alter regulatory processes controlling  growth 
and differentiation.  In many tumors individual  cells can be 
found  that  spontaneously  undergo  partial  or  complete 
differentiation  or can be induced to differentiate  by various 
agents  (Pierce,  1974).  These observations have  indicated 
that not all cells in a given tumor are necessarily in the same 
state of transformation  and some can be reverted to a benign 
phenotype.  Induction  of differentiation  has  actually  been 
proposed as an alternative  approach to conventional therapy 
of cancer (Metcalf, 1983; Spremulli and Dexter,  1984; Sar- 
torelli, 1985; Sachs, 1987). To investigate factors and condi- 
tions which may influence  the balance between the trans- 
formed state and the differentiated  phenotype, we have used 
clonal cell lines  isolated from a  dimethylbenzanthracene- 
induced rat rhabdomyosarcoma which were shown to exert 
different capacities to differentiate  in vitro (Gerharz  et al., 
1988).  In  contrast  to  normal  myogenic  cells  in  which 
differentiation can be induced by the mere removal of serum 
components,  only a minute proportion of the rhabdomyosar- 
coma cen line BA-Han-IC forms myotubes under these con- 
ditions.  The majority of cells requires retinoic  acid (RA)  ~ 
or a variety of other inducing agents for effective differentia- 
tion (Gabbert et al.,  1988; Gerharz et al.,  1989). The BA- 
Han-lB cell line isolated from the same tumor can not be 
triggered  to differentiate  to the complete muscle phenotype 
by inducing agents, although it appears to be of skeletal mus- 
cle origin as judged by its morphology and the expression of 
desmin and muscle creatine kinase (Gerharz  et al.,  1988, 
1989). In the absence of inducers both cell lines appear as 
mononuclear,  rapidly dividing  rhabdomyoblasts. 
The development of muscle cells has become a preferred 
model system  to study molecular mechanisms underlying 
cellular differentiation.  A group of myogenic  control pro- 
teins encoded by the MyoD gene family has recently been 
identified  (for review  see Olson,  1990;  Emerson,  1990; 
1. Abbreviations used in this paper: bHLH, basic-helix-loop-helix;  MHC, 
myosin heavy chain; RA, retinoic acid; RAR, retinoic acid receptor. 
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(Davis et al., 1987; Braun et al., 1989a),  myogenin (Wright 
et al.,  1989;  Edmondson and Olson,  1989;  Braun et al., 
1989a),  Myf-5 ~rann  et al.,  1989b),  and  MRF4/hercu- 
lin/Myf-6 (Rhodes and Konieczny, 1989; Miner and Wold, 
1990; Braun et al.,  1990) have been isolated and shown to 
possess the capacity to convert 101"1/2 fibroblasts and a vari- 
ety of other nonmuscle cells to the myogenic lineage. All of 
these proteins contain a highly conserved basic region adja- 
cent to a sequence motif that is believed to form two am- 
phipathic helices which are connected by a short intervening 
loop structure.  The basic-helix-loop-helix  (bHLH) domain 
is  responsible  for  heterooligomerization  and  sequence- 
specific  DNA binding  to a  DNA sequence referred to as 
E-box (Davis  et al.,  1990;  Murre et al.,  1989a,b).  This 
E-box motif consisting  of the highly degenerate DNA con- 
sensus sequence CANNTG was found to be present in con- 
trol elements of many muscle-specific genes where it medi- 
ates transcriptionai  activation  by the interaction  with the 
muscle-specific regulatory bHLH proteins (reviewed in O1- 
son, 1990; Emerson, 1990). The biochemical properties of 
these proteins and their exclusive expression in skeletal mus- 
cle and embryonic muscle progenitor cells suggest that their 
primary biological activity may be to activate the transcrip- 
tion of typical muscle genes. 
To investigate the role of the myogenic control factors in 
the differentiation-competent  rhatxlomyosarcoma  cell line 
BA-Han-IC and in the differentiation-refractory  counterpart 
BA-Han-IB, we analyzed the expression and activity of the 
various members of the MyoD family. We were particularly 
interested in the effects that RA acting as a differentiation in- 
ducing agent may exert on the activity of the myogenic fac- 
tors and their genes. Here, we report that MyoD1 is constitu- 
tively expressed in the inducible cell line BA-Han-IC but not 
in the uninducible line  BA-Han-IB. Administration  of RA 
results  in  a  delayed  transcriptional  activation  of  the  myogenin 
genc in BA-Han-IC but not in BA-Han-IB cells.  Activation 
of myogenin genc expression is dependent on protein  and 
DNA  synthesis  suggesting  that  RA may act  rather  indirectly. 
Our results  provide  evidence that  the  block  of  differentiation 
in the rhabdomyosarcoma cell  line  BA-Han-IC may be de- 
pendent on the lack of myogenin expression.  However, a 
mechanism that  inhibits  the  transcription  activating  function 
of  MyoD1 may also  play  an important role  for  the inability 
of  these  cells  to differentiate  in the absence of  the inducer 
RA. Both events  may in fact  be related. 
Materials and Methods 
Cell Culture and DNA Transfections 
The isolation and characterization of the rat rhabdomyosarcoma cell lines 
BA-Han-IB and BA-Han-IC have been described previously (Gerharz et ai., 
1988, 1989). Cells were cultured in DME supplemented with 10% FCS, 
penicillin, and streptomycin. Ctflture media and sera were purchased from 
Gibco Laboratory  (Eggenstein,  Germany).  To induce differentiation,  RA 
(scrva Inc.) was added to a final concentration of 1 ~M from a 5 mM stock 
solution prepared in 95 % ethanol. Medium was routinely chan~od  after 3 d. 
Rat L6 and mouse C2C12 celis (Yaffe  and Saxel, 1977) were obtained from 
the American Type Culture Collection (Rockville, MD) and were cultured 
as described  elsewhere (Braun et al., 1992; Sniminen et ai., 1991). 
Rhabdomyosarcoma  cells were stably transfected  with 1 ~g of super- 
coiled pSV2-neo plasmid conferring geneticin (G418) resistance and 20/zg 
of pEMSV-Myf4 by use of the calcium-phosphate  precipitation  method. 
G418-resistant  colonies  were  selected  in medium  containing  400 ~g/ml 
G418 (Geneticin; Gibco Laboratories,  Grand Island, NY). Transient trans- 
fections were performed as described previously (Braun et al., 1989c). CAT 
activity was determined by standard procedures  (Gorman,  1985) two days 
after transfecfion. Transfection efliciencies were controlled by cotransfec- 
tion of 5 #g RSV-Bgal  plasmid and CAT activity was standardized according 
to ~-galactosidase activity obtained  in the same cellular extracts. 
Reporter Plasmids and Expression Vectors 
Myf4L-CAT reporter containing 1.1 kb of the human Myf-4 gene promoter 
driving the CAT gene has been described previously (Saiminen et ai., 1991). 
MCK4R-CAT plasmid containing  four oligomerized  MyoDl-binding sites 
upstream  of the thymidine kinase TATA-box linked to the CAT gene has 
been provided by A. Lassar (Harvard Medical School, Boston, MA) (Wein- 
traub  et ai.,  1991). TK-CAT reporter  plasmid  has been obtained  by G. 
Schlitz (German Cancer Research Center, Heidelberg,  Germany).  MLC- 
CAT plasmid containing the muscle-specific enhancer of  the rat myosin light 
chain 1/3 gene and the MLC1 core promoter linked to the CAT gene has 
been published previously ~senthal et al., 1990). The expression vector 
pEMSV-Myf4 has been described  (Braun et ai., 1989a). 
Isolation of  RNA and Northern Blot Analysis 
RNA was isolated  from tissue culture  cells by the guanidinium  method 
(Chomzynski  and Sacchi,  1987). 5-10  ￿  106 cells yielded between 200 
and 300 ~g of total RNA. Glyoxylation, agarose gel electrophoresis,  RNA 
transfer,  and  hybridization  conditions  have  been  described  previously 
(Braun et al., 1989b). Briefly, 25 ~g of total RNA was separated on gels, 
transferred onto PALL Biodyne Membrane (Portsmouth, UK), and hybrid- 
ized with 1-3  ￿  106 cpm/ml of radioactively labeled hybridization probe 
(sp act  1-2  ￿  10  a cpm/~g obtained  through random  priming  with [32p] 
dCTP) (3,000 Ci/mmol).  Filters were hybridized in 50%  formamide, 5x 
Denhardi's solution, 5 ￿  SSC (1￿  SSC contains 0.15 M sodium chloride and 
0.015 M sodium citrate), 50 mM sodium phosphate, 0.1% SDS at 42~  for 
18 h. Filters were washed in 0.1% SSC, 0.1% SDS at 55~  for 30 vain in 
several steps. 
The following probes were used for hybridization: (a) the mouse MyoDl 
probe  was obtained  as a 800-bp  HpalI/EcoRI fragment  from the cloned 
eDNA (Davis et ai.,  1987) representing the 3' noncoding region;  (b) the 
myogenin probe was prepared as a 700-bp fragment from the rat eDNA as 
described previously (Sassoon et at., 1989); (c) the GAPDH probe was a 
1,100-bp segment of the mouse glyceraldehyde phosphate dehy~ 
eDNA: (d) the Id eDNA probe has been provided by H. Weintraub (Fred 
Hutchinson Cancer Center, Seattle, WA) and has been described (Benezra 
et ai., 1990); and (e) mouse Myf-5 and Myf-6 probes have been described 
previously (OR et ai., 1991; Bober et aL,  1991). 
Immunohistochemicai Staining of  Culture Cells 
Cells were seeded on microscopic slides and cultured under the described 
conditions: ceils were fixed in methanol for 5 min followed by acetone treat- 
ment at  -20~  for 10 s, and air dried.  The mAb against rat myogenin, 
kindly provided by W. Wright (University of Texas, Dallas, TX) was applied 
for 30 rain at room temperature in a moist chamber. Slides were rinsed in 
PBS solution and incubated with the antimouse IgG second antibody using 
the avi~me-biotin  complex and peroxidase  staining for detection (Vecta- 
stain Kit; ABC, Burlingame, CA). 
Results 
MyoD1 Is Expressed Constitutively in the Inducible 
Rhabdomyosarcoma Cell Line BA-Han-IC 
RA has been shown previously to induce terminal differenti- 
ation in rhabdomyosarcoma cells (Gerharz et al.,  1989).  In 
the two clonal cell subpopulations, BA-Han-IB  and BA-Han- 
1(2, isolated from a rat rhabdomyosarcoma,  administration 
of RA resulted in a differential effect leading to myogenic 
differentiation in BA-Han-IC but not in Ba-Han-lB cells ~ig. 
1 A). To examine the expression of the various genes encod- 
ing muscle-specific regulatory bHLH proteins in these two 
cell lines, we determined the mRNA levels using sequence- 
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and myogenin mRNAs in the 
rhabdomyosarcoma cells BA- 
Han-lC but not in BA-Han-IB: 
Induction by retinoic acid. (A) 
lmmunohistochemical  stain- 
ing of BA-Han-IB  (a and  b) 
and BA-Han-IC (c and d) cells 
with the mAb MF-20 directed 
against  sarcomeric  myosin 
heavy chain.  Cells were cul- 
tured in the presence (a and c) 
and absence (b and d) of RA 
for 3 d. Myosin positive cells 
appear  dark  by  peroxidase 
staining using the ABC Vec- 
tastain  system.  (B)  Northern 
blot analysis  of RNA (20/,g) 
isolated from BA-Han-IB (lanes 
I  and  2)  and  BA-Han-IC 
(lanes 3 and 4) cells grown in 
the  absence  (-)  or presence 
(+)  of  retinoic  acid  (RA).  RNA 
from  differentiated  C2C12 
myotubes was used as control 
(lane 5).  The blots were hy- 
bridized with mouse MyoD1 
cDNA (MyoD1), rat myogenin 
cDNA (myogenin) and mouse 
GAPDH eDNA (GAPDH) as 
described  under  Materials 
and Methods. Approximately 
2  x  10  6 cpm/ml of each probe 
(spec.  activity:  1-3  X  l0  s 
cpm/~g) were used. Blots hy- 
bridized to MyoDl/myogenin 
and GAPDH were exposed on 
film for 48 h and 6 h, respec- 
tively. Bar,  70/zm. 
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and MRF4. Total cellular RNA isolated from both cell lines 
which have been cultured for 5 d in the absence or presence 
of RA, was analyzed on Northern blots.  As shown in Fig. 
1 B, in growing BA-Han-IC cells (clone C) MyoD1 mRNA 
accumulated to a  level comparable to that observed in C2 
myoblasts, regardless whether or not RA was present.  In 
contrast, no MyoD1 mRNA was detected in BA-Han-IB cells 
(clone  B).  Myogenin  mRNA  was  absent  (Ba-Han-lB 
cells/clone B) or expressed at very low levels 03A-Han-IC 
cells/clone C) when cells were cultured in the absence of 
RA. Addition of RA to BA-Han-IC cells, however, resulted 
in a large increase of myogenin mRNA, whereas it had no 
effect on BA-Han-IB cells. This differential response to RA 
was not due to a different expression of retinoic acid recep- 
tors (RAR) in BA-Han-IB and BA-Han-IC cells as both lines 
have  been  shown  to  accumulate  comparable  levels  of 
mRNAs encoding ct and g RAR (Ramp et al., 1992). Myf-5 
and MRF4 mRNAs were undetectable in both cell lines, in 
the absence and presence of RA (data not shown).  These 
results indicate, in line with previous observations on several 
established myogenic cells, that the muscle forming capacity 
of  BA-Han-IC ceils is associated with the constitutive expres- 
sion of MyoD1 and that expression of myogenin only starts 
at the onset of muscle cell differentiation. In contrast, BA- 
Han-lB cells which lack all of the myogenic control factors 
can not be induced to differentiate suggesting that the myo- 
genic potential of rhabdomyosarcoma cells may be deter- 
mined by the expression of MyoD1. 
Activation of the Myogenin Gene Is a Late Response to 
Induction by Retinoic Acid 
We have noticed that morphological differentiation of BA- 
Figure  2. Time course of myo- 
genin mRNA accumulation in 
BA-Han-IC cells treated with 
RA.  RNA  from BA-Han-IC 
cells treated for 6 h with RA 
was isolated at various times 
following RA removal (lanes 
1--4) or from cells growing for 
72 h without RA (lane 5). C2 
cells  were  used  as  controls 
(lane 6). In a parallel experi- 
ment RNA was isolated from 
cells cultured for 48 h follow- 
ing RA treatment for intervals 
of 1 to 5 h (lanes 7-11  ) or from 
cells cultured for 72 h without 
RA (lane 12). Hybridizations 
were performed with myogenin 
cDNA  and  mouse  GAPDH 
cDNA to control RNA load- 
ing as described in the legend 
to Fig.  1. 
Han-lC cells required at least 2 to 3 d after the addition of 
RA. To determine the precise time course of the accumula- 
tion  of myogenin mRNA,  total  RNA  isolated  from cells 
grown in the presence of RA for 12,  24, 48, and 72 h was 
analyzed on Northern blots. We found consistently that myo- 
genin mRNA started to accumulate 48 h after the induction 
by  RA  reaching  levels  similar  to  or  exceeding those  in 
differentiated C2 myotubes and persisting at nearly constant 
levels throughout the rest of the culturing period (Fig.  2, 
lanes 1-4 and 6). Cells grown in 10% FBS or in 5% horse 
serum for up to 72 h did not activate myogenin expression 
above a  marginal level (Fig.  2,  lane 5) and also failed to 
differentiate except for a  minor proportion of cells which 
formed small myotubes (<1%).  To define the time period 
during which RA was required in order to induce myogenin 
synthesis, cells were incubated in RA containing medium for 
intervals of 1 to 5 h after which they were refed with fresh 
medium  without  RA.  After  incubation  for  an  additional 
48 h, RNA was isolated and hybridized on Northern blots 
with the myogenin-specific probe. As shown in Fig. 2, myo- 
genin mRNA accumulated to similar levels in all cultures 
treated with RA for 1 to 5 h indicating that the inducer was 
only required for a period of 1 h or less (Fig. 2, lanes 7-12). 
Taken together, these results suggested to us that the activa- 
tion of myogenin transcription may not be a direct effect of 
the RA receptor complex on the myogenin gene but may 
rather require additional intermediate processes. 
The Induction of  Myogenin Transcription by RA Is 
Dependent on Protein and DNA Synthesis 
To test this idea, BA-Han-IC cells were induced with RA and 
treated with cycloheximide, an inhibitor of  protein synthesis. 
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~nin  mRNA in  BA-Han- 
1C cells is inhibited by cyclo- 
heximide. Northern blot anal- 
ysis of uninduced and induced 
BA-Han-IC cells treated with 
cyclohexemide  (C/-/X) at vari- 
ous times following RA addi- 
tion (A). As illustrated in B 
cells were grown for 48 h ei- 
ther without RA (1), or with 
RA for 6 h (2), and 12 h (3), 
or with RA plus CHX for 6 h 
(4), with RA for 6 h and CHX 
added 42 h later (5) or with 
CHX added 24  h  after RA 
(lane 6). Lanes 1-6 in A cor- 
respond to numbers 1-6 in B. 
Cycloheximide was added either simultaneously together 
with RA or at various times following the induction. RNA 
was isolated 48 h after the administration of RA. As shown 
in Fig. 3, inhibition of protein synthesis prevented the ex- 
pression of  myogenin  mRNA when cycloheximide  was pres- 
ent at any time during the first 30 h after treatment with RA. 
However,  cyclohexemide had no effect when it was added 
42 h after RA treatment. This result clearly indicated that in 
order to induce myogenin  transcription with RA, active pro- 
tein synthesis is  required  for at least 30 h.  The  fact that 
myogenin  gene activation is dependent on the synthesis of ad- 
ditional proteins again argues against a direct interaction of 
the RA-receptor complex with the myogenin gene. 
The onset of myogenin synthesis followed the induction by 
RA with a lag period of approximately 48 h. As it seemed 
unlikely that the synthesis of newly made protein would take 
two days, we wondered whether the activation of the myo- 
genin gene may also require DNA replication. To test this 
proposition, cells were induced with RA and treated either 
with aphidicoline or hydroxyurea, both agents that inhibit 
DNA synthesis. As shown in Fig. 4 A, in the presence of ei- 
ther inhibitor, RA failed to induce transcription of  myogenin 
mRNA whereas the accumulation of GAPDH mRNA used 
as an unrelated control was unaffected. This result indicated 
that induction of the myogenin gene in BA-Han-IC cells not 
only required protein synthesis but also DNA replication. As 
it is known that methylation of DNA may block the expres- 
sion of genes and demethylation may occur during replica- 
tion of DNA, we investigated the possible role of demethyla- 
tion for the activation of the myogenin gene.  Cells were 
pretreated with 5-azacytidine in three cycles for 9 d each. In- 
dividual colonies were picked after each round of azacyti- 
dine treatment and  isolated DNA  was  digested with the 
isoschizomeric restriction endonucleases HpaII and MspI to 
ascertain the degree of hypomethylation (data not shown). 
The azacytidine treated cells containing maximally hypo- 
methylated DNA were then tested for the induction of myo- 
genin expression by RA. As shown in Fig. 4 B, myogenin 
mRNA accumulated 48 h after the addition of RA in a time 
pattern identical to the untreated control cells. If hypomethy- 
lation of  the myogenin  or any other gene had been a prerequi- 
site for the induction of myogenin expression, one would 
have expected accelerated onset of transcription in cells that 
had been pretreated with azacytidine. However, our result 
suggests that methylation  of  DNA did not play a role for myo- 
genin gene expression and therefore can not explain the re- 
quirement for DNA synthesis. 
MyoDI Present in BA-Han-IC Cells Fails to 
Transactivate Muscle-specific Reporter Genes 
While BA-Han-IB cells did not express any of the myogenic 
determination factors (see Fig. 1) which provides a possible 
reason why these cells may not be  induced for terminal 
differentiation,  BA-Han-IC  cells  constitutively  expressed 
MyoD1 but nevertheless almost completely failed to activate 
the myogenic differentiation program in the absence of RA. 
To analyze whether this was due solely to the inability of 
MyoD1  to transactivate muscle-specific genes or if addi- 
tional factors might be missing, we examined the activation 
of reporter genes containing either complex muscle-specific 
enhancers or a  minimal enhancer containing a  tetrameric 
E-box (MyoDl-binding site). The CAT reporter plasmids, 
Myf4L-CAT  containing  the  human  myogenin  promoter 
(Salminen et al.,  1991),  MCK4R-CAT containing a  tetra- 
meric MyoD1 binding site in front of the thymidine kinase 
TATA-box (Lassar et al.,  1991), and MLC-CAT containing 
the muscle-specific enhancer of the rat myosin light chain 
gene (Rosenthal et al.,  1990),  were transiently transfected 
into BA-Han-IC cells and assayed for CAT activity 48 h later. 
The TK-CAT plasmid containing only the basal TK-promoter 
was used as non-muscle control. In parallel cultures, pEMSV- 
MyoD plasmid which expresses high levels of MyoD1 was 
cotransfected with each of the CAT-reporter  constructs. In 
cells transfected with the reporter plasmids alone, none of 
the muscle-specific CAT genes was activated above a mar- 
ginal background  level indicating  that the endogenous MyoD1 
was unable to support their transcription (see Fig. 5). In con- 
trast,  cells cotransfected with the plasmid pEMSV-MyoD 
leading to forced expression of exogenous MyoD1 showed a 
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sis picvem RA-induced accumulation 
of myogenin mRNA; demethylation 
of  DNA  does  not  accelerate  RA- 
induced transcription of myogenin. 
RNA from BA-Han-IC cells treated 
for 48 h with RA Oane 1), RA plus 
aphidicoline (lane  2),  or  RA  plus 
hydroxyurea (lane 3) was hybridized 
to  myogenin  and  GAPDH-specific 
probes (A).  RNA from BA-Han-IC 
cells  pretreated  with  5-azacytidine 
for  three  cycles  (see  text)  and  in- 
duced for differentiation  by the addi- 
tion of RA for l, 6, 12, 24, and 48 h 
(B, lanes 1-5) was hybridized  to myo- 
genin and GAPDH specific probes. 
RNA from differentiated C2 cells was 
used as control (lanes A4 and B6). 
Figure  5.  Transactivation  of 
muscle-specific reporter genes 
by cotransfected pEMSV-MyoD 
in BA-Han-IC cells. The indi- 
cated reporter plasmids (5/zg) 
were  transiently  transfected 
into BA-Han-IC together with 
pEMSV-MyoD plasmid (5/zg) 
or  pEMSV-c~-scribe  (5  #g) 
used as control. CAT activities 
were determined 2 d following 
transfection as described un- 
der Materials and Methods. 
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in BA-Han-IB  and BA-Han-I  C Cells Stably Transfected 
with  pEMSV-Myf4, or  pEMSV-MyoD 
Transfected  Analyzed  Differentiating  Percent of 
Ceils  plasmids*  colonies*  coloniesw  conversion 
BA-Han-IC  pEMSV-MyoD  15  9  60 
pEMSV-Myf4  12  6  50 
pEMSV-tx-scribe  10  0  0 
pEMSV-MyoD  12  0  0 
pEMSV-Myf4  12  0  0 
pEMSV-cx-scribe  12  0  0 
BA-Han-IB 
* All transfections were performed with 1 ~g pSV2-neo plasmid and 20 pg 
pEMSV expression plasmids followed by selection of G418-resistant colonies. 
* Randomly picked G418-resistant colonies were analyzed for spontaneous 
differentiation in normal growth medium. 
Colonies showing MHC-positive cells detected by immunostaining with the 
rnonoclonal antibody MF20. 
large increase of CAT activity driven by the muscle-specific 
promoters.  The TK.CAT control plasmid showed moderate 
activity independent of additional MyoD expressed from the 
pEMSV-MyoD construct. It is worthwhile noting that during 
the time span of these transient experiments  (2 d), addition 
of RA had no positive effect on the lack of muscle-specific 
transactivation  nor did it enhance the activity of exogenous 
MyoD1 (data not shown). As endogenous MyoD1 was unable 
to transactivate  even the simple MCK4R-CAT gene that pre- 
sumably does not require additional factors, we interpret this 
result as evidence that  MyoD1 apparently accumulates in 
BA-Han-IC cells in a biologically inactive  form or alterna- 
tively is present at a concentration that is not sufficient to ac- 
tivate transcription.  Elevated levels of MyoD1 alleviated the 
block of transcriptional  activation,  even in the absence of 
retinoic  acid. It should be mentioned  that BA-Han-IC cells 
stably transfected with pEMSV-MyoD also exhibited a large 
proportion of differentiating  and myosin positive colonies 
(see Table I). 
The Inhibitory HLH Protein Id Is Downregulated  in 
Rhabdomyosarcoma Cells Treated with Retinoic Acid 
A possible explanation for the inactive MyoD1 in BA-Han-IC 
cells could be the presence of an inhibitor.  The negative mus- 
cle regulatory protein Id has been proposed to be involved 
in the control of MyoD activity in proliferating  myoblasts 
(Benezra et ai., 1990). Id is a HLH protein which lacks the 
basic region and therefore can not bind to DNA. It presum- 
ably prevents DNA binding of other HLH proteins as a com- 
petitive inhibitor since it effectively dimerizes with El2 and 
MyoD1 and thereby forms complexes which contain only 
one active half-site of  the DNA-binding domain. The expres- 
sion of Id is stimulated  by serum and withdrawal of serum, 
for instance in myoblast cultures, results in its downregula- 
tion  whereby the inhibitory  effect on  MyoD1  is released 
(Benezra et al., 1990). To test whether Id may play a regula- 
tory role in the rhabdomyosarcoma cell lines,  we analyzed 
Id mRNA levels following the induction by RA. As shown 
in Fig. 6, Id mRNA was present at moderate concentrations 
in both rhabdomyosarcoma cell lines and in normal L6 myo- 
blasts when cultured in medium containing serum. Id mRNA 
continued to accumulate for 24 h after the addition of RA 
and then declined to almost undetectable levels at 48 h. The 
decrease of Id mRNA occurred independent of serum as 
cells were kept in medium containing  10% FCS throughout 
the experiment.  This  result showed that Id expression is 
downregulated by RA treatment in differentiating  BA-Han- 
1C as well as in differentiation-defective  BA-Han-IB cells and 
also in normal L6 myoblasts which do not differentiate under 
these conditions.  Interestingly,  the time course of Id mRNA 
repression correlated inversely to the induction of myogenin 
mRNA in BA-Han-IC cells (compare Fig.  1) but the func- 
tional significance of this correlation is rather unclear,  since 
Id downregulation  also occurred in non-differentiating  cells 
which do not express myogenin mRNA. 
Forced  Expression of  Myogenin in BA-Han-IC 
Cells Bypasses the Requirement of  RA to Induce 
Terminal Differentiation 
From the data presented above, it became evident that the in- 
ability of BA-Han-IC cells to differentiate in the absence of 
RA was associated with inactivation  of the MyoD1 protein 
and the failure to express myogenin.  RA-induced differen- 
tiation  was always accompanied by the expression of myo- 
genin.  The functional  relationship  of these various observa- 
tions, however, remained obscure. Moreover, it was unclear 
whether factors different from MyoD and myogenin may also 
contribute to the suppression of  the differentiated phenotype. 
To address this problem, we examined whether constitutive 
expression of myogenin would be sufficient to induce termi- 
nal differentiation  and to bypass the requirement for the in- 
ducer RA. BA-Han-IC were cotransfected with the plasmid 
pEMSV-Myf4 expressing the human myogenin (Myf-4) pro- 
tein and pSV2-neo conferring genedcin ((3418) resistance. 
Control cells were transfected with pSV2-neo plasmid alone. 
Colonies were selected in medium containing  G418 and as- 
sayed for morphological differentiation and the expression of 
myogenin (Fig. 7) and myosin heavy chain (MHC) by immu- 
nostaining  (data not shown). The same experiment was also 
performed in parallel with BA-Han-IB cells. Whereas the 
majority of G418-resistant ItA-Han-IC cells transfected with 
pEMSV-Myf4 expressed myogenin and fused spontaneously 
to MHC  + myotubes, <1% of the pSV2-neo transfected con- 
trol cells showed myogenin expression and formed myotubes 
(Table I and Fig. 7, c and e). The extent of myogenin expres- 
sion arid myotube formation within the pEMSV-Myf4 trans- 
fected BA-Han-lC colonies was similar to that obtained in 
RA-treated cells but decreased successively with each serial 
passage of the cells. This phenomenon is most likely due to 
the selective loss of postmitotic myoblasts and differentiated 
myotubes (Fig.  7, d  and e).  In contrast,  BA-I-Ian-IB cells 
transfected  with pEMSV-Myf4 completely failed  to form 
myotubes, although 70-80% of the cells showed positive nu- 
clear staining  for myogenin (Table I, Fig. 7, a and b). This 
result then indicated that the inhibition  of differentiation  in 
BA-Han-IC cells could be obfiterated by the constitutive  ex- 
pression of myogenin from a viral LTR promoter suggesting 
that no additional  factors acting  in parallel or downstream 
of myogenin may be required. Moreover,  it showed that the 
block  in  BA-Han-IC  cells  was  probably  not  due  to  a 
dominant-acting  negative mechanism. In contrast, BA-Han- 
1B cells could not be rescued for the muscle phenotype by 
the expression of myogenin and therefore must be inhibited 
by another mechanism. 
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Figure 7. Muscle differentiation  occurs in 
BA-Han-IC  but  not  in BA-Han-IB  cells 
stably  transfccted  with  pEMSV-Myf4. 
BA-Han-IB (a)  and BA-Han-IC cells  (c) 
stably transfected  with pSV2-nco plasmid 
alone or stable colonies of both cell lines 
transfccted  with pEMSV-Myf4 (BA-Han- 
1B, b; R4-Han-IC, e) were immunostalned 
with  a  mAb to  myogenin  (Myf4).  BA- 
Han-lB cells  show  no expression of the 
nuclear  antigen  myogenin  (a),  whereas 
BA-Han-IC cells express myogenin in <1% 
of the  cells,  some in mononuclcar (ar- 
rows) and some in myotubes (arrowhead, 
c).  Approximately 80%  of the pEMSV- 
Myf4 transfccted cells (b and d) express 
myogenin (arrows),  readily  distinguish- 
able from the translucent appearance of 
nuclei lacking m3x~nin (circles). Whereas 
myogenin  expressing cells of  the subpopu- 
lation BA-Han-IC (e) frequently form myo- 
tubes, none of the myogenin positive cells 
of  subpopulation  BA-Han-IB  (b)  fuse. 
The  pEMSV-Myf4 transfected  BA-Han- 
1C colonies (e) resemble  the appearance 
of the BA-Han-IC cells grown in RA (d). 
Note that the particular colony shown here 
has  already  been  passaged  three  times  and 
therefore has lost a considerable number of 
myogenin positive cells.  Bar, 50 urn. 
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The enhanced proliferative capacity of transformed cells is 
generally accompanied by a  reduced capability to acquire 
the terminally differentiated phenotype. To begin to inves- 
tigate possible mechanisms which may explain why tumor 
cells fail to differentiate, we have used two rhabdomyosar- 
coma cell lines BA-Han-IB  and BA-Han-IC both of which 
have been isolated from the same dimethylbenzanthracene- 
induced rat tumor. Although both subpopulations express 
desmin,  a  generally accepted marker for myogenic cells, 
their myogenic potentials are vastly different. As we have 
shown here, BA-Han-IB cells did not express any of the four 
known myogenic factors and failed to form myotubes either 
spontaneously or upon induction with RA. In contrast, BA- 
Han-lC cells accumulated MyoD1 and showed low level of 
spontaneous  differentiation that was  greatly enhanced by 
RA. These results confirm numerous reports that the muscle 
phenotype is always associated with the expression of one or 
several myogenic control genes and absence of  myogenic fac- 
tors abrogates the ability to form muscle cells. Interestingly, 
many if not all human rhabdomyosarcoma tumors or cell 
lines derived thereof express also MyoD1 and/or one of the 
other related myogenic factors (Scrable et al., 1989; Hiti et 
al., 1989; Clark et al., 1991). Similar to nontransformed, es- 
tablished myogenic cell lines, BA-Han-IC tumor cells begin 
to accumulate myogenin at the onset of terminal differentia- 
tion.  However,  the activation of myogenin expression re- 
quires induction with RA, in contrast to normal muscle ceils 
which start differentiation without any inducing agents when 
serum has been removed. In fact, BA-Han-IC cells seemed 
to have lost the responsiveness to the differentiation sup- 
pressing effect of serum as they readily formed myotubes in 
high serum concentrations when RA was also provided. Al- 
ternatively, RA may have induced factors that directly or in- 
directly interfere with signals elicited by serum components, 
such as growth factors and mitogens. In any case, the induc- 
tion of muscle differentiation by RA seems to be unique for 
BA-Han-IC cells as various established myogenic cell lines 
and other rhabdomyosarcoma cells do not respond to RA 
with differentiation (H.  H.  Arnold,  unpublished observa- 
tions). Although we have not analyzed the immediate effects 
of RA in these cells, we have identified late results, such as 
the initiation of myogenin gene expression and the subse- 
quent activation of the complete muscle differentiation pro- 
gram. Myogenin gene transcription in these cells was depen- 
dent on de novo protein synthesis and surprisingly also on 
DNA synthesis. It is presently unclear whether myogenin 
transcription in normal muscle cells also may require protein 
and DNA synthesis after serum withdrawal, although the rel- 
atively long time required for terminal differentiation of all 
established myogenic cell lines may suggest this. The impor- 
tance of DNA-synthesis can not be explained by demethyla- 
tion of DNA as we have shown that extensive pretreatment 
of the cells with azacytidine did not accelerate the kinetics 
of myogenin gene activation by RA. One can only speculate 
that alterations of the chromatin conformation which may 
occur during DNA replication could be a prerequisite for the 
activating effect by RA. 
Inspection of ~1,100 bp of the 5'-upstream sequence of  the 
human myogenin gene (Myf-4), which were sufficient to 
mediate muscle-specific and regulated expression (Salminen 
et  al.,  1991), revealed  no  sequence  homology to  a  RA 
receptor-binding  site.  This  observation supported  the in- 
terpretation that RA does not activate transcription of the 
myogenin gene by direct interaction but rather leads to syn- 
thesis or activation of other transcription factors which then 
activate the myogenin gene. Our previous results and those 
of others (Braun et ai.,  1989b;  Thayer et al.,  1989)  have 
shown that transfections of nonmuscle cells with plasmids 
expressing one myogenic factor led to the activation of the 
endogenous  genes  and  the  related  genes  encoding other 
members of the MyoD protein family. The auto- and cross- 
activation of the myogenin gene could also be demonstrated 
in transient transfection experiments using a CAT reporter 
construct driven by the Myf-4 promoter and expression vec- 
tors for MyoD or one of the related proteins serving as trans- 
activators (Salminen et al.,  1991). These experiments indi- 
cated that the muscle bHLH proteins directly or through 
transcription factors activated by them are involved in tran- 
scription of the myogenin gene. A potential candidate for an 
immediate activator is the MEF-2 transcription complex, as 
the myogenin promoter contains a MEF-2 binding site (Sal- 
minen et al., 1991; unpublished results) and the MEF-2 tran- 
scription complex was shown to be induced in nonmuscle 
cells by the expression of MyoD1  (Lassar et al.,  1991). If 
MyoD1 directly or indirectly can activate transcription of the 
myogenin  gene, why then was myogenin  not expressed in BA- 
HanqC cells? 
In the present report, we have demonstrated that MyoD1 
was expressed normally in BA-Han-IC rhabdomyosarcoma 
cells but it obviously lacked the biological activity to func- 
tion as a muscle-specific transcription factor. It is conceiv- 
able that this inactivity is either due to posttranscriptional 
modifications of MyoD1 or to the presence of an inhibitor. 
Alternatively, the absence of auxiliary factor(s) normally re- 
quired for MyoD1 activity, could also be the cause. Although 
we have shown that the inhibitory HLH protein Id was ex- 
pressed in rhabdomyosarcoma cells and its expression was 
down-regulated in RA treated cells, we find it unlikely that 
this contributes specifically to the differentiation block in 
BA-Han-IC  cells  for the  following reasons:  (a)  Id is  ex- 
pressed to very low levels and its downregulation in the pres- 
ence of RA does not correlate with differentiation in a posi- 
tive way (Id mRNA also decreases in L6 and BA-Han-IB 
cells, nevertheless these cells do not differentiate under these 
conditions); (b) the Id expressing BA-Han-IC cells could be 
forced to transactivate muscle-specific genes by transfection 
of pEMSV-MyoD1  which expresses high levels of MyoD1. 
This indicates that Id is not sufficient to inactivate all E12- 
like HLH proteins that are required for MyoD to form DNA- 
binding complexes. The fact that overexpression of MyoD1 
restored the muscle phenotype in BA-Han-IC cells also ar- 
gues against a mechanism that depends on additional posi- 
five-acting factors which may be lacking but rather suggests 
that MyoD1 is probably affected by posttranscriptional modi- 
fications in these ceils. We have not yet addressed the nature 
of these modifications, but phosphorylation is a plausible 
one, since MyoD1 is known to be a phosphoprotein (Tapscott 
et al.,  1988). 
Transfection of BA-Han-IC cells with plasmids constitu- 
tively expressing myogenin led to strongly increased sponta- 
neous differentiation without induction by RA. Therefore we 
believe that no events downstream of myogenin expression 
Arnold et al.  /7,.4 Induced Differentiation of Rhabdomyosarcoma Cells  885 affect  the differentiation  capacity  of these tumor cells.  In 
fact, myogenin appears to serve as a switch to initiate termi- 
nal differentiation.  Taken together,  our results demonstrate 
that both inactivation of MyoD1 protein and the lack of myo- 
genin expression may  contribute  to the nondifferentiating 
phenotype.  Whether both events are functionally  related re- 
mains to be seen. 
Terminal differentiation of muscle cells has been shown to 
be inhibited by mutant-activated  ras protein  (Konieczny  et 
al.,  1989; Lassar et al.,  1989; Schneider  et al.,  1987; Gos- 
sett et al., 1988; Olson et ai., 1987; Payne et al., 1987) and 
by excess levels of fos (Lassar et al.,  1989). Both oncogene 
products reduce transcription of the endogenous MyoD and 
myogenin genes.  Constitutive  expression of MyoD from a 
stably transfected cDNA can restore the muscle phenotype 
in cells expressing mutant ras and los (Lassar et al., 1989). 
Since MyoD1 expression is not affected in BA-Han-IC rhab- 
domyosarcoma ceils, it appears unlikely that ras and fos gene 
products are involved in the malignant transformation. Pre- 
liminary results on the expression pattern of these oncogenes 
are in agreement with this interpretation (unpublished obser- 
vations).  Expression of the oncogenic tyrosine kinases v-src 
and v-fps and transforming growth factor receptors (v-erbB) 
have  also been  shown to  attenuate  muscle differentiation 
(Falcone et al.,  1985;  Fiszmann and Fuchs, 1975;  Holtzer 
et al., 1975). A temperature-sensitive  v-src protein prevents 
differentiation of quail primary muscle cells without affect- 
ing the accumulation of MyoDl transcripts (Faicone et ai., 
1991), similar to the situation observed in BA-Han-IC cells. 
This  observation  is  interesting  because  it  illustrates  that 
some oncogenes may block differentiation without affecting 
the synthesis of MyoD protein but rather by interference with 
its activity.  Similarly,  forced expression of the nuclear on- 
cogene  product  c-myc  inhibits  myogenic  differentiation 
(Schneider et al., 1987; Denis et al.,  1987) and the MyoD1 
and myogenln-induced  muscle conversion of 3T3 fibroblasts 
(Miner and Wold,  1991). This latter effect can not be over- 
come by constitutive and high-level expression of MyoD and 
myogenin,  again  suggesting  a  mechanism that inactivates 
functions of these proteins rather than interfering with their 
expression. We have recently shown that the transforming re- 
gion of Ela prevents muscle differentiation and inhibits the 
transcription activating  function of myogenic HLH control 
proteins but also the expression of myogenin (Braun et al., 
1992). Enkemann et al.  (1990) have also demonstrated that 
Ela dowuregulates the expression of MyoD1 and myogenln. 
None of the described phenotypes generated by these various 
oncogenes agrees completely with the phenotype of the BA- 
Han-lC cells. One can therefore speculate that other mecha- 
nisms act in these ceils to inhibit differentiation. In this con- 
text it is interesting  to mention that the bacterial  pertussis 
toxin which interferes with the activity of inhibitory G-pro- 
teins  can  induce  differentiation  of BA-Han-IC  cells  (A. 
Salminen and H. H. Arnold, unpublished observations)  sug- 
gesting that Gi-protein-dependent  signal transduction path- 
ways may be involved.  We are currently  investigating  this 
possibility.  The fact that BA-Han-IB ceils never acquire the 
differentiated muscle phenotype, although they do express 
desmin, and MCK (Gerharz et al.,  1989) argues for a com- 
pletely different and maybe more complex mode by which 
these cells have been transformed. 
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